- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02293486
Study of Pomegranate Juice in the Modulation of Oxidative Stress Markers in Endurance-based Athletes
November 13, 2014 updated by: Néstor Vicente-Salar, Universidad Miguel Hernandez de Elche
The purpose of this study is to evaluate modifications of plasma protein carbonyls and malondialdehyde levels in endurance-based athletes after three weeks of pomegranate juice consumption.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Early Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Perform specific endurance training sessions
- More than 1 hour per session and more than 3 sessions per week
- Have participated recently in a half marathon or similar event
Exclusion Criteria:
- Intake of antioxidant or anti-inflammatory supplementation
- Present a chronic disorder
- Non-smoker
- No-alcoholic beverage consumption
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Arm that followed all the protocols with the exception of the pomegranate juice intake.
|
|
Experimental: Pomegranate Juice
Arm that followed all the protocols and the pomegranate juice intake.
|
Intake of 200 ml of pomegranate juice or pomegranate juice dilution during 21 days after exercise.
Other Names:
|
Experimental: Pomegranate Juice Dilution
Arm that followed all the protocols and the pomegranate juice dilution (1:1) intake.
|
Intake of 200 ml of pomegranate juice or pomegranate juice dilution during 21 days after exercise.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Protein carbonyls levels changes in plasma
Time Frame: day 0 and 22
|
Protein carbonyl derivatives were determined using an adaptation of the colorimetric method published in Levine et al. (1994) based in the formation of a stable 2,4-dinitrophenyl (DNP) hydrazone product after the addition of 2,4-dinitrophenylhydrazine (DNPH) to tha plasma.
Protein carbonyls were calculated as nmoles·mg-1 protein
|
day 0 and 22
|
Malondialdehyde levels changes in plasma
Time Frame: day 0 and 22
|
Malondialdehyde was determined by high pressure liquid chromatography (HPLC) with fluorescence detection according to the method described by Laporta et al. (2007).
Malondialdehyde levels were calculated as nmoles·g-1 protein
|
day 0 and 22
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood biochemical parameters changes in plasma
Time Frame: day 0 and 22
|
Blood biochemical parameters is a composite outcome measure consisting in circulating plasma glucose (mg·dL-1), HDL-cholesterol (mg·dL-1), triglycerides (mg·dL-1), ferritin (ng·mL-1), lactate (mg·dL-1), sodium (mEq·L-1), potassium (mEq·L-1), creatine kinase (U·L-1), aspartate aminotransferase (U·L-1) and alanine aminotransferase (U·L-1) were analyzed through biochemistry methods.
|
day 0 and 22
|
C-reactive protein levels changes in plasma
Time Frame: day 0 and 22
|
Determination by immunoassay of C-reactive protein (ng·mL-1) levels in plasma.
|
day 0 and 22
|
Soluble E-selectin levels changes in plasma
Time Frame: day 0 and 22
|
Determination by immunoassay of soluble E-selectin (ng·mL-1) levels in plasma.
|
day 0 and 22
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Director: Enrique Roche, PhD, University Miguel Hernandez
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000 May;71(5):1062-76. doi: 10.1093/ajcn/71.5.1062.
- Trombold JR, Reinfeld AS, Casler JR, Coyle EF. The effect of pomegranate juice supplementation on strength and soreness after eccentric exercise. J Strength Cond Res. 2011 Jul;25(7):1782-8. doi: 10.1519/JSC.0b013e318220d992.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
February 1, 2013
Study Registration Dates
First Submitted
November 10, 2014
First Submitted That Met QC Criteria
November 13, 2014
First Posted (Estimate)
November 18, 2014
Study Record Updates
Last Update Posted (Estimate)
November 18, 2014
Last Update Submitted That Met QC Criteria
November 13, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- GRA 01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oxidative Stress
-
FertilysRecruiting
-
Idaho State UniversityCompletedOxidative StressUnited States
-
Unidad de Investigacion Medica en Enfermedades...Completed
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Coordenação de Aperfeiçoamento...Completed
-
Complife Italia SrlMacrofarm Srl; Icim International SrlCompleted
-
Indonesia UniversityIndonesia-MoHCompleted
-
Assiut UniversityCompleted
-
Universidad Católica San Antonio de MurciaCompleted
-
Oregon State UniversityCompleted
-
Nationwide Children's HospitalWithdrawn
Clinical Trials on Pomegranate juice
-
University of LeedsCompletedHyperglycaemiaUnited Kingdom
-
Hillel Yaffe Medical CenterUnknown
-
University of WashingtonCompletedInflammation | Cardiovascular Disease | End Stage Renal DiseaseUnited States
-
National Research Council, SpainIMDEA Food; CEIP (primary school) Jara Carrillo (Alcantarilla, Murcia, Spain); IES (secondary school) Alcántara (Alcantarilla, Murcia, Spain)CompletedGenotype, Metabotype and Dietary HabitsSpain
-
Brigham and Women's HospitalUniversity of California, Los Angeles; POM Wonderful LLCCompletedIntrauterine Growth RestrictionUnited States
-
University of California, Los AngelesCompletedSkin Photoaging, Inflammation and Skin Pathogenic BacteriaUnited States
-
Rambam Health Care CampusUnknownEndometriosis | PCOS | Male Factor Infertility | Advised Maternal Age
-
University of Colorado, DenverPOM Wonderful LLCCompletedType 2 Diabetes MellitusUnited States
-
University of California, Los AngelesTerminatedInflammation | ErythemaUnited States
-
University of California, Los AngelesCompletedCardiovascular Diseases